Highland Global Allocation Fund의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Shattuck Labs Inc 주요 수익원은 Pharmaceutical이며, 최신 수익 발표에서 수익은 1,657,000입니다. 지역별로는 United States이 Shattuck Labs Inc의 주요 시장이며, 수익은 1,657,000입니다.
Highland Global Allocation Fund은 수익성이 있나요?
no, 최신 재무제표에 따르면 Shattuck Labs Inc의 순손실은 $0입니다.
Highland Global Allocation Fund에 부채가 있나요?
no, Shattuck Labs Inc의 부채는 0입니다.
Highland Global Allocation Fund의 발행 주식은 몇 주인가요?
Shattuck Labs Inc의 총 발행 주식은 0주입니다.
주요 통계
이전 종가
$8.22
시가
$8.22
일일 범위
$8.13 - $8.24
52주 범위
$7.23 - $10.64
거래량
62.5K
평균 거래량
71.1K
배당수익률
--
EPS(TTM)
--
시가총액
$181.8M
HGLB란 무엇인가요?
Highland Global Allocation Fund is a US-based company operating in industry. The company is headquartered in Dallas, Texas. The company went IPO on 2019-02-19. Highland Global Allocation Fund (the Fund) is a diversified, closed-end management investment company. The Fund seeks to achieve its investment objectives by investing in a portfolio of United States and foreign equity, debt and money market securities. The Fund intends to invest at least 50% of its net assets in equity securities and at least 40% of its net assets in securities of non-United States issuers. The Fund may also invest in debt securities of any kind, including debt securities of varying maturities, debt securities paying a fixed or fluctuating rate of interest, inflation-indexed bonds, structured notes, loan assignments, loan participations, asset-backed securities, debt securities convertible into equity securities, and securities issued or guaranteed by the United States. The Fund’s investment adviser is Highland Capital Management Fund Advisors, L.P.